AKT1 and colorectal carcinoma: We found that the treatment of CRC cell suspensions with AKT inhibitors (AZD5363 and MK-2206), rather than ERK inhibitor (SCH772984), downregulated ATOH8 (Additional file 3: Figure S8c-e).